Vaxil Bio Ltd (VXLLF)
0.005
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Vaxil Bio Max Drawdown (5Y): 99.25% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.25% |
March 31, 2024 | 99.25% |
February 29, 2024 | 99.25% |
January 31, 2024 | 99.25% |
December 31, 2023 | 99.25% |
November 30, 2023 | 99.25% |
October 31, 2023 | 99.25% |
September 30, 2023 | 99.25% |
August 31, 2023 | 99.25% |
July 31, 2023 | 99.25% |
June 30, 2023 | 99.25% |
May 31, 2023 | 99.25% |
April 30, 2023 | 99.25% |
March 31, 2023 | 99.25% |
February 28, 2023 | 99.25% |
January 31, 2023 | 99.25% |
December 31, 2022 | 99.25% |
November 30, 2022 | 97.98% |
October 31, 2022 | 97.32% |
September 30, 2022 | 97.32% |
August 31, 2022 | 97.32% |
July 31, 2022 | 97.32% |
June 30, 2022 | 97.32% |
May 31, 2022 | 96.60% |
April 30, 2022 | 94.64% |
Date | Value |
---|---|
March 31, 2022 | 94.64% |
February 28, 2022 | 94.64% |
January 31, 2022 | 94.64% |
December 31, 2021 | 94.64% |
November 30, 2021 | 92.44% |
October 31, 2021 | 92.44% |
September 30, 2021 | 92.44% |
August 31, 2021 | 92.44% |
July 31, 2021 | 92.44% |
June 30, 2021 | 92.44% |
May 31, 2021 | 92.44% |
April 30, 2021 | 92.44% |
March 31, 2021 | 92.44% |
February 28, 2021 | 92.44% |
January 31, 2021 | 92.44% |
December 31, 2020 | 92.44% |
November 30, 2020 | 92.44% |
October 31, 2020 | 92.44% |
September 30, 2020 | 92.44% |
August 31, 2020 | 92.44% |
July 31, 2020 | 92.44% |
June 30, 2020 | 92.44% |
May 31, 2020 | 92.44% |
April 30, 2020 | 92.44% |
March 31, 2020 | 92.44% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.44%
Minimum
May 2019
99.25%
Maximum
Dec 2022
95.12%
Average
92.44%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -3.617 |
Beta (5Y) | -2.632 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 234.0% |
Historical Sharpe Ratio (5Y) | -0.1409 |
Historical Sortino (5Y) | -0.5524 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 49.81% |